| 臺大學術典藏 |
2022-03-22T08:25:46Z |
Chlorine dioxide gas generation using rotating packed bed for air disinfection in a hospital
|
Trinh V.M;Yuan M.-H;Chen Y.-H;Wu C.-Y;Kang S.-C;Chiang P.-C;Hsiao T.-C;Huang H.-P;Zhao Y.-L;Lin J.-F;Huang C.-H;Yeh J.-H;Lee D.-M.; Huang H.-P; HAN-PANG HUANG et al. |
| 臺大學術典藏 |
2022-03-22T08:25:38Z |
Design of a Bone-Guided Cochlear Implant Microsystem with Monopolar Biphasic Multiple Stimulations and Evoked Compound Action Potential Acquisition and Its in Vivo Verification
|
Wang S.-H;Huang Y.-K;Chen C.-Y;Tang L.-Y;Tu Y.-F;Chang P.-C;Lee C.-F;Yang C.-H;Hung C.-C;Liu C.-H;Ker M.-D;Wu C.-Y.; Liu C.-H; CHIEN-HAO LIU et al. |
| 臺大學術典藏 |
2022-03-10T05:59:28Z |
Association of obesity, diabetes, and risk of tuberculosis: Two population-based cohorts
|
Lin H.-H.; Wu C.-Y.; Wang C.-H.; Fu H.; Lönnroth K.; YI-CHENG CHANG; Huang Y.-T. |
| 臺大學術典藏 |
2022-03-10T02:31:39Z |
OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis
|
Bai L.-Y.; Weng J.-R.; Chiu C.-F.; Wu C.-Y.; Yeh S.-P.; Sargeant A.M.; PO-HAN LIN; Liao Y.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
Chiang Y.-C.; PO-HAN LIN; Lu T.-P.; Kuo K.-T.; Tai Y.-J.; Hsu H.-C.; Wu C.-Y.; Lee C.-Y.; Shen H.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-01T08:19:52Z |
Biatrial paradoxical embolism identified by three-dimensional transesophageal echocardiography
|
Cheng H.-L.; Huang C.-H.; MING-JIUH WANG; Lin Y.-J.; Wu C.-Y.; Lin P.-L. |
| 臺大學術典藏 |
2022-03-01T08:19:38Z |
Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats
|
Yang S.-J.; Fan C.-N.; MING-JIUH WANG; Fan S.-Z.; Tsai J.-C.; Sun W.-Z.; Chan W.-S.; Yeh Y.-C.; Cheng Y.-J.; Yeh Y.-C.; Liu C.-M.; Shih P.-Y.; Chen S.-H.; Chiu C.-T.; Chao A.; Wu C.-Y.; NTUH Center of Microcirculation Medical Research (NCMMR) |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2022-02-22T05:34:15Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
